As biopharma deals keep pace, M&A volumes languish
The BioWorld Insider Podcast

As biopharma deals keep pace, M&A volumes languish

Jul 9, 2021
14:22
S1 · E3
-(0)

About this episode

Biopharma deal-making activity, a closely watched marker of industry health, was alive and well in the second quarter. BioWorld Senior Analyst Karen Carey sifts through the numbers. Hosted on Acast. See acast.com/privacy for more information.

Comments

Rate this episode

Episode Details

Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy